{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:55:38Z","timestamp":1793310938163,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["493624047"],"award-info":[{"award-number":["493624047"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZA 428\/28-1"],"award-info":[{"award-number":["ZA 428\/28-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZA 428\/29-1"],"award-info":[{"award-number":["ZA 428\/29-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZA 428\/30-1"],"award-info":[{"award-number":["ZA 428\/30-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00134-026-08399-1","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:31:13Z","timestamp":1776673873000},"page":"1023-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Implementation of a kidney protection strategy to prevent acute kidney injury after major surgery in high-risk patients identified by biomarkers: a systematic review and individual participant data meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"52","author":[{"given":"Thilo","family":"von Groote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Bormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Tunnicliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"G\u00f6cze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahan","family":"Sadjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lui G.","family":"Forni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-1714","authenticated-orcid":false,"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"12","key":"8399_CR1","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00134-023-07169-7","volume":"49","author":"A Zarbock","year":"2023","unstructured":"Zarbock A, Weiss R, Albert F, Rutledge K, Kellum JA, Bellomo R, Grigoryev E, Candela-Toha AM, Demir ZA, Legros V, Rosenberger P, Gal\u00e1n Men\u00e9ndez P, Garcia Alvarez M, Peng K, L\u00e9ger M, Khalel W, Orhan-Sungur M, Meersch M, Investigators EPIS-AKI (2023) Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med 49(12):1441\u20131455. https:\/\/doi.org\/10.1007\/s00134-023-07169-7","journal-title":"Intensive Care Med"},{"issue":"8","key":"8399_CR2","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honor\u00e9 PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41(8):1411\u20131423. https:\/\/doi.org\/10.1007\/s00134-015-3934-7","journal-title":"Intensive Care Med"},{"key":"8399_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/RRU.S385856","volume":"16","author":"R Singh","year":"2024","unstructured":"Singh R, Watchorn JC, Zarbock A, Forni LG (2024) Prognostic biomarkers and AKI: potential to enhance the identification of post-operative patients at risk of loss of renal function. Res Rep Urol 16:65\u201378. https:\/\/doi.org\/10.2147\/RRU.S385856","journal-title":"Res Rep Urol"},{"key":"8399_CR4","first-page":"1","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO Clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1\u2013138","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"8399_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/cc12503","volume":"17","author":"K Kashani","year":"2013","unstructured":"Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (London, England) 17(1):25. https:\/\/doi.org\/10.1186\/cc12503","journal-title":"Crit Care (London, England)"},{"issue":"1","key":"8399_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13054-020-02984-6","volume":"24","author":"D Titeca-Beauport","year":"2020","unstructured":"Titeca-Beauport D, Daubin D, Van Vong L, Belliard G, Bruel C, Alaya S, Chaoui K, Andrieu M, Rouquette-Vincenti I, Godde F, Pascal M, Diouf M, Vinsonneau C, Klouche K, Maizel J (2020) Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study. Crit Care (London, England) 24(1):280. https:\/\/doi.org\/10.1186\/s13054-020-02984-6","journal-title":"Crit Care (London, England)"},{"issue":"11","key":"8399_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00134-016-4670-3","volume":"43","author":"M Meersch","year":"2017","unstructured":"Meersch M, Schmidt C, Hoffmeier A et al (2017) Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 43(11):1551\u20131561. https:\/\/doi.org\/10.1007\/s00134-016-4670-3","journal-title":"Intensive Care Med"},{"issue":"2","key":"8399_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1213\/ANE.0000000000005458","volume":"133","author":"A Zarbock","year":"2021","unstructured":"Zarbock A, K\u00fcllmar M, Ostermann M et al (2021) Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg 133(2):292\u2013302. https:\/\/doi.org\/10.1213\/ANE.0000000000005458","journal-title":"Anesth Analg"},{"issue":"6","key":"8399_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/SLA.0000000000002485","volume":"267","author":"I G\u00f6cze","year":"2018","unstructured":"G\u00f6cze I, Jauch D, G\u00f6tz M et al (2018) Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study. Ann Surg 267(6):1013\u20131020. https:\/\/doi.org\/10.1097\/SLA.0000000000002485","journal-title":"Ann Surg"},{"key":"8399_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01717-9","author":"A Zarbock","year":"2025","unstructured":"Zarbock A, Ostermann M, Forni L et al (2025) A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial. Lancet (London, England). https:\/\/doi.org\/10.1016\/S0140-6736(25)01717-9. (Advance online publication)","journal-title":"Lancet (London, England)"},{"issue":"9","key":"8399_CR11","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/sim.2050","volume":"24","author":"CT Smith","year":"2005","unstructured":"Smith CT, Williamson PR, Marson AG (2005) Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Stat Med 24(9):1307\u20131319. https:\/\/doi.org\/10.1002\/sim.2050","journal-title":"Stat Med"},{"issue":"10","key":"8399_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s00134-023-07163-z","volume":"49","author":"HJ de Grooth","year":"2023","unstructured":"de Grooth HJ, Parienti JJ (2023) Heterogeneity between studies can be explained more reliably with individual patient data. Intensive Care Med 49(10):1238\u20131241. https:\/\/doi.org\/10.1007\/s00134-023-07163-z","journal-title":"Intensive Care Med"},{"issue":"3","key":"8399_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00134-018-5134-8","volume":"44","author":"HJ de Grooth","year":"2018","unstructured":"de Grooth HJ, Postema J, Loer SA, Parienti JJ, Oudemans-van Straaten HM, Girbes AR (2018) Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates. Intensive Care Med 44(3):311\u2013322. https:\/\/doi.org\/10.1007\/s00134-018-5134-8","journal-title":"Intensive Care Med"},{"issue":"4","key":"8399_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00134-021-06370-w","volume":"47","author":"J Juschten","year":"2021","unstructured":"Juschten J, Tuinman PR, Guo T, Juffermans NP, Schultz MJ, Loer SA, Girbes ARJ, de Grooth HJ (2021) Between-trial heterogeneity in ARDS research. Intensive Care Med 47(4):422\u2013434. https:\/\/doi.org\/10.1007\/s00134-021-06370-w","journal-title":"Intensive Care Med"},{"key":"8399_CR15","doi-asserted-by":"publisher","first-page":"c221","DOI":"10.1136\/bmj.c221.Published2010Feb5","volume":"340","author":"RD Riley","year":"2010","unstructured":"Riley RD, Lambert PC, Abo-Zaid G (2010) Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 340:c221. https:\/\/doi.org\/10.1136\/bmj.c221.Published2010Feb5","journal-title":"BMJ"},{"issue":"16","key":"8399_CR16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"Stewart LA, Clarke M, Rovers M et al (2015) Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA 313(16):1657\u20131665. https:\/\/doi.org\/10.1001\/jama.2015.3656","journal-title":"JAMA"},{"key":"8399_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71.Published2021Mar29","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.Published2021Mar29","journal-title":"BMJ"},{"issue":"7","key":"8399_CR18","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00134-025-08015-8","volume":"51","author":"A Zarbock","year":"2025","unstructured":"Zarbock A, Forni L, Koyner JL et al (2025) Preventing acute kidney injury and its longer-term impact in the critically ill. Intensive Care Med 51(7):1331\u20131347. https:\/\/doi.org\/10.1007\/s00134-025-08015-8","journal-title":"Intensive Care Med"},{"issue":"9","key":"8399_CR19","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s00134-024-07560-y","volume":"50","author":"A Zarbock","year":"2024","unstructured":"Zarbock A, Forni LG, Koyner JL et al (2024) Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement. Intensive Care Med 50(9):1426\u20131437. https:\/\/doi.org\/10.1007\/s00134-024-07560-y","journal-title":"Intensive Care Med"},{"issue":"10","key":"8399_CR20","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s00134-025-08080-z","volume":"51","author":"JA Kellum","year":"2025","unstructured":"Kellum JA, Zarbock A (2025) Why interventions to prevent acute kidney injury are needed now and why preventing long-term outcomes will only come later. Intensive Care Med 51(10):1898\u20131900. https:\/\/doi.org\/10.1007\/s00134-025-08080-z","journal-title":"Intensive Care Med"},{"issue":"1","key":"8399_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s13054-023-04641-0.Published2023Oct9","volume":"27","author":"CY See","year":"2023","unstructured":"See CY, Pan HC, Chen JY et al (2023) Improvement of composite kidney outcomes by AKI care bundles: a systematic review and meta-analysis. Crit Care 27(1):390. https:\/\/doi.org\/10.1186\/s13054-023-04641-0.Published2023Oct9","journal-title":"Crit Care"},{"issue":"1","key":"8399_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12882-025-03955-1","volume":"26","author":"FR Ahmed","year":"2025","unstructured":"Ahmed FR, Al-Yateem N, Nejadghaderi SA, Gamil R, AbuRuz ME (2025) Effect of acute kidney injury care bundle on kidney outcomes in cardiac patients receiving critical care: a systematic review and meta-analysis. BMC Nephrol 26(1):17. https:\/\/doi.org\/10.1186\/s12882-025-03955-1","journal-title":"BMC Nephrol"},{"issue":"1","key":"8399_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12882-025-04349-z","volume":"26","author":"Y Huang","year":"2025","unstructured":"Huang Y, Guan L, Sun C (2025) Effect of acute kidney injury care bundles on patient prognosis: a systematic review and meta-analysis. BMC Nephrol 26(1):519. https:\/\/doi.org\/10.1186\/s12882-025-04349-z","journal-title":"BMC Nephrol"},{"issue":"4","key":"8399_CR24","doi-asserted-by":"publisher","first-page":"e0302179","DOI":"10.1371\/journal.pone.0302179","volume":"19","author":"S Zhang","year":"2024","unstructured":"Zhang S, Chen Y, Zhou F, Wang L, Luo Q (2024) Effect of care bundles for acute kidney injury: a systematic review and meta-analysis. PLoS ONE 19(4):e0302179. https:\/\/doi.org\/10.1371\/journal.pone.0302179","journal-title":"PLoS ONE"},{"key":"8399_CR25","doi-asserted-by":"publisher","first-page":"j573","DOI":"10.1136\/bmj.j573","volume":"356","author":"DJ Fisher","year":"2017","unstructured":"Fisher DJ, Carpenter JR, Morris TP, Freeman SC, Tierney JF (2017) Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach? BMJ 356:j573. https:\/\/doi.org\/10.1136\/bmj.j573","journal-title":"BMJ"},{"issue":"3","key":"8399_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7861\/clinmedicine.13-3-233","volume":"13","author":"S Finlay","year":"2013","unstructured":"Finlay S, Bray B, Lewington AJ et al (2013) Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units. Clin Med (Lond) 13(3):233\u2013238. https:\/\/doi.org\/10.7861\/clinmedicine.13-3-233","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"8399_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/ALN.0b013e3181979440","volume":"110","author":"S Kheterpal","year":"2009","unstructured":"Kheterpal S et al (2009) Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 110(3):505\u2013515. https:\/\/doi.org\/10.1097\/ALN.0b013e3181979440","journal-title":"Anesthesiology"},{"issue":"4","key":"8399_CR28","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.cir.95.4.878","volume":"95","author":"GM Chertow","year":"1997","unstructured":"Chertow GM, Lazarus JM, Christiansen CL et al (1997) Preoperative renal risk stratification. Circulation 95(4):878\u2013884. https:\/\/doi.org\/10.1161\/01.cir.95.4.878","journal-title":"Circulation"},{"issue":"1","key":"8399_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.jvca.2015.06.017","volume":"30","author":"J Hu","year":"2016","unstructured":"Hu J, Chen R, Liu S, Yu X, Zou J, Ding X (2016) Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 30(1):82\u201389. https:\/\/doi.org\/10.1053\/j.jvca.2015.06.017","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"8","key":"8399_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1164\/rccm.201401-0077OC","volume":"189","author":"A Bihorac","year":"2014","unstructured":"Bihorac A, Chawla LS, Shaw AD et al (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189(8):932\u2013939. https:\/\/doi.org\/10.1164\/rccm.201401-0077OC","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08399-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08399-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08399-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:41:33Z","timestamp":1780933293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08399-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8399"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08399-1","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TvG, EB, MM, DT, IG, MS have no potential conflict of interest to declare. AZ has received consulting fees from Astute-Biomerieux, Baxter, Bayer, Novartis, Guard Therapeutics, AM Pharma, Paion, Viatris, Dropshot, Fresenius, research funding from Astute-Biomerieux, Fresenius, Baxter, and speaker fees from Astute-Biomerieux, Fresenius, Baxter. LF received funding and honoraria from Baxter and consulting fees from AstraZeneca, Baxter, and SphingoTec. HG received consultancy fees for trilinear bio ventures, Novartis, and Talphera, speaker fees from bioMerieux and research grants from Baxter and biomMrieux.\u00a0JAK holds royalties or licenses from CytoSorbents, and J3RM holds stock options of and is contracted by Spectral Medical and received honoraria from AstraZeneca, Bayer, Novartis, bioM\u00e9r\u00edeux, Mitsubishi Tenabe, and Chugai Pharma. AZ and JAK are named inventors on multiple patents (assigned to the Universities of M\u00fcnster and Pittsburgh), involving TIMP-2 and IGFBP7, unrelated to the use of these biomarkers for AKI detection or risk stratification. Urinary TIMP-2 and IGFBP7 are measured in the commercially available NephroCheck assay marketed by bioM\u00e9rieux; author relationships with Astute Medical\/bioM\u00e9rieux are disclosed above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}